Info@ThinkPinkRocks.com

New Article: New Drugs for Ovarian Cancer Patients

A new class of drugs could be a significant step forward in the treatment of ovarian cancer, one of the most lethal forms of the disease.

The drugs, known as PARP inhibitors, are thought to help the body slow the disease’s progression by helping to prevent cancer cells from repairing themselves after chemotherapy treatment, thereby shrinking tumors and delaying relapses.

You can read the rest of this important article at the Wall Street Journal by clicking here.

Share

Leave a Reply